Piramal Pharma Limited (PPLPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 180.91B |
| Enterprise Value | 225.42B |
| P/E Ratio | -64.17 |
| PEG Ratio | 0.65 |
| Price/Sales Ratio | 2.37 |
| Price/Book Ratio | 2.45 |
| Enterprise/Revenue | 2.87 |
| Enterprise/EBITDA | 23.22 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.04 |
| Operating Margin | 0.01 |
AD
Management Effectiveness
| Return On Assets | -0.02 |
| Return On Equity | -0.04 |
Income Statement
| Revenue | 88.69B |
| Revenue/Share | 70.39 |
| Gross Profit | 23.83B |
| EBITDA | 9.22B |
| Net Income | -3.26B |
| Diluted EPS | -2.46 |
Balance Sheet
| Total Cash | 13.55B |
| Total Cash/Share | 10.76 |
| Total Debt | 56.75B |
| Total Debt/Equity | 0.7 |
| Current Ratio | 1.51 |
| Book Value Per Share | 64.78 |
Price History
| 52-Week Change | -18.42 |
| 52-Week High | 220.85 |
| 52-Week Low | 132.3 |
| Moving Average 50 Days | 166.16 |
| Moving Average 200 Days | 171.29 |
Statistics
| Average Volume | 5.29M |
| Shares Outstanding | 1.33B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.14 |
| Trailing Annual Dividend Yield | 0.09 |
| Payout Ratio | -0.06 |
| Last Split Factor | 1023:1000 |
| Last Split Date | August 02, 2023 |
AD
